<DOC>
	<DOCNO>NCT01204333</DOCNO>
	<brief_summary>Background : Endovascular thrombolysis , without mechanical clot removal ( ET ) , may beneficial subgroup patient cerebral venous sinus thrombosis ( CVT ) , poor prognosis despite treatment heparin . Published experience ET promising , base case series control trial . Objective : The main objective TO-ACT trial determine ET improve functional outcome patient severe form CVT Study design : The TO-ACT trial design multi-centre , prospective , randomize , open-label , blind endpoint ( PROBE ) trial . Study population : Patients eligible radiologically proven CVT , high probability poor outcome ( define presence one follow risk factor : mental status disorder , coma , intracranial hemorrhagic lesion thrombosis deep cerebral venous system ) responsible physician uncertain ET standard anti-coagulant treatment well . Intervention : Patients randomize receive either ET standard therapy ( therapeutic dos heparin ) . ET consist local application alteplase urokinase within thrombosed sinus , and/or mechanical thrombectomy . Glasgow coma score , NIH stroke scale relevant laboratory parameter assess baseline . Endpoints : The primary endpoint modify Rankin scale ( mRS ) 12 month . The important secondary outcome mRS , mortality recanalization rate 6 month . Major intra- extracranial hemorrhagic complication within one week follow intervention principal safety outcome . Results analyze accord `` intention-to-treat '' principle . Assessment study endpoint carry accord standardize questionnaire blind neurologist research nurse involve treatment patient . Study size : To detect 50 % relative reduction mRS≥2 ( 40 20 % ) , 164 patient ( 82 treatment arm ) include ( two-sided alpha , 80 % power ) . Nature extent burden risk associate participation , benefit group relatedness : Included patient may benefit directly ET . Complications ET , notably intracranial hemorrhage , constitute important risk study .</brief_summary>
	<brief_title>Thrombolysis Anticoagulation Cerebral Venous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Sinus Thrombosis , Intracranial</mesh_term>
	<mesh_term>Intracranial Thrombosis</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<criteria>1 . Cerebral venous thrombosis , confirm cerebral angiography ( intraarterial contrast injection ) , magnetic resonance venography compute tomographic venography . 2 . Severe form CVT high chance incomplete recovery , define presence one follow risk factor 1 . Intracerebral hemorrhagic lesion due CVT 2 . Mental status disorder 3 . Coma ( Glasgow coma scale &lt; 9 ) 4 . Thrombosis deep cerebral venous system 3 . Uncertainty treat physician ET standard heparin therapy optimal therapy patient . Age le 18 year Duration diagnosis randomization 10 day Recurrent CVT Any thrombolytic therapy within last 7 day Pregnancy ( woman puerperium may include ) Isolated cavernous sinus thrombosis Isolated intracranial hypertension ( without focal neurological sign , exception papilloedema 6th cranial nerve palsy ) Cerebellar venous thrombosis 4th ventricle compression hydrocephalus , require surgery Contraindication anticoagulant thrombolytic treatment 1. document generalized bleeding disorder 2. concurrent thrombocytopenia ( &lt; 100 x 10E9/L ) 3. document severe hepatic renal dysfunction , interfere normal coagulation 4. uncontrolled severe hypertension ( diastolic &gt; 120 mm Hg ) 5. know recent ( &lt; 3 month ) gastrointestinal tract hemorrhage ( include he¬morrhage rectal hemorrhoid ) Any know associated condition ( terminal cancer ) poor short term ( 1 year ) prognosis independent CVT Clinical radiological sign impend transtentorial herniation due large spaceoccupying lesion ( e.g . large cerebral venous infarct hemorrhage ) Recent ( &lt; 2 week ) major surgical procedure ( include lumbar puncture ) severe cranial trauma Known allergy contrast fluid use endovascular procedure thrombolytic drug use particular centre Previously legally incompetent prior CVT No inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cerebral venous sinus thrombosis</keyword>
	<keyword>Cerebral venous thrombosis</keyword>
	<keyword>Sinus Thrombosis , Intracranial</keyword>
	<keyword>Endovascular thrombolysis</keyword>
	<keyword>Thrombolysis</keyword>
	<keyword>Thrombectomy</keyword>
</DOC>